7:15am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Major Biotechs
The October 14 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Companies
/Healthcare
AMGEN Inc
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 11:51pm ET
AMGN Coverage
Page 2410:35am ET
Health and Healthcare
Top Health Care Earnings Coming Next Week
Earnings season is now in full swing, and we have put together a preview of Bristol-Myers, AbbVie and some of the other top players in the health care sector.
12:25pm ET
Health and Healthcare
How Just 10 States Saved Almost $120 Billion in 2015 Using Generic Drugs
Americans generally would like to spend less money on health care. One way that this can be and will be accomplished is through the continued use and expanded use of generic drugs.
9:55am ET
Health and Healthcare
Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains
These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.
7:10am ET
Health and Healthcare
Short Sellers Have Mixed Views on Major Biotechs
If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a stock implosion down the road.
7:50am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The September 15 short interest data have been compared with the previous report, and short interest moves were upward across most of these selected biotech stocks.
8:15am ET
Health and Healthcare
How Much Will Consumers Save on New Humira Biosimilar?
In a time when government wrangling about drug prices is more than commonplace, news of a biosimilar for the mega-blockbuster Humira being approved took the backseat to many other things.
8:25am ET
Health and Healthcare
RBC Says These 4 Top Biotechs Could Have Big Upside Potential
An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four top biotech companies may be a solid play now.
7:05am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The August 31 short interest data have been compared with the previous report, and short interest decreased for most of these selected biotech stocks.
8:40am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across these selected biotech stocks.
8:50am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the July 29 settlement date and short interest decreased across these selected biotech stocks.
12:35pm ET
Health and Healthcare
Why Advaxis Shares Could More Than Double, Even After the Amgen Deal
According to one analyst, Advaxis shares could still easily more than double, even after news broke that biotech giant Amgen will become its partner.
Jon C. Ogg 9:25am ET
Health and Healthcare
RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains
Finally, concerns about biotech seem to be waning. An RBC research report notes that at the recent political conventions there was little to no mention of drug pricing.
11:50am ET
Health and Healthcare
What to Look for in Amgen Earnings
Amgen is expected to report its second-quarter financial results after the markets close on Wednesday. Will it go the same way as Gilead Sciences did earlier this week?
Chris Lange 7:50am ET
Health and Healthcare
Major Biotechs See Increased Short Interest Bets
The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected biotech stocks.